Toll Free: 1-888-928-9744

Vichem Chemie Research Ltd. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Vichem Chemie Research Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Vichem Chemie Research Ltd. - Product Pipeline Review - 2014', provides an overview of the Vichem Chemie Research Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vichem Chemie Research Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vichem Chemie Research Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vichem Chemie Research Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Vichem Chemie Research Ltd.'s pipeline products

Reasons to buy

- Evaluate Vichem Chemie Research Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vichem Chemie Research Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vichem Chemie Research Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vichem Chemie Research Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vichem Chemie Research Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vichem Chemie Research Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Vichem Chemie Research Ltd. Snapshot 6
Vichem Chemie Research Ltd. Overview 6
Key Information 6
Key Facts 6
Vichem Chemie Research Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
Vichem Chemie Research Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Vichem Chemie Research Ltd. - Pipeline Products Glance 15
Vichem Chemie Research Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Vichem Chemie Research Ltd. - Drug Profiles 17
Small Molecules to Inhibit CDK9 for HIV-1 Infection 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
VI-4053 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
VI-4055 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
VI-460 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
VI-87 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
VID-45110 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AX-20017 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Cancer Stem Cell Killing Program 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit EGFR for Oncology 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
VI-11498 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
VI-11527 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
VI-11530 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
VI-11562 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
VI-14585 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
VI-15843 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
VI-15910 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
VI-16665 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
VI-17299 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
VI-18469 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
VI-9376 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Vichem Chemie Research Ltd. - Pipeline Analysis 37
Vichem Chemie Research Ltd. - Pipeline Products by Target 37
Vichem Chemie Research Ltd. - Pipeline Products by Route of Administration 38
Vichem Chemie Research Ltd. - Pipeline Products by Molecule Type 39
Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action 40
Vichem Chemie Research Ltd. - Dormant Projects 41
Vichem Chemie Research Ltd. - Locations And Subsidiaries 42
Head Office 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44
List of Tables
Vichem Chemie Research Ltd., Key Information 6
Vichem Chemie Research Ltd., Key Facts 6
Vichem Chemie Research Ltd. - Pipeline by Indication, 2014 8
Vichem Chemie Research Ltd. - Pipeline by Stage of Development, 2014 10
Vichem Chemie Research Ltd. - Monotherapy Products in Pipeline, 2014 11
Vichem Chemie Research Ltd. - Partnered Products in Pipeline, 2014 12
Vichem Chemie Research Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 13
Vichem Chemie Research Ltd. - Preclinical, 2014 15
Vichem Chemie Research Ltd. - Discovery, 2014 16
Vichem Chemie Research Ltd. - Pipeline by Target, 2014 37
Vichem Chemie Research Ltd. - Pipeline by Route of Administration, 2014 38
Vichem Chemie Research Ltd. - Pipeline by Molecule Type, 2014 39
Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action, 2014 40
Vichem Chemie Research Ltd. - Dormant Developmental Projects,2014 41 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify